Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals

Background To compare drug regimens across clinical trials in Parkinson's disease (PD) conversion formulae between antiparkinsonian drugs have been developed. These are reported in relation to levodopa as the benchmark drug in PD pharmacotherapy as ‘levodopa equivalent dose’ (LED). Currently, t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Movement disorders Jg. 38; H. 7; S. 1236 - 1252
Hauptverfasser:	Jost, Stefanie T., Kaldenbach, Marie‐Ann, Antonini, Angelo, Martinez‐Martin, Pablo, Timmermann, Lars, Odin, Per, Katzenschlager, Regina, Borgohain, Rupam, Fasano, Alfonso, Stocchi, Fabrizio, Hattori, Nobutaka, Kukkle, Prashanth Lingappa, Rodríguez‐Violante, Mayela, Falup‐Pecurariu, Cristian, Schade, Sebastian, Petry‐Schmelzer, Jan Niklas, Metta, Vinod, Weintraub, Daniel, Deuschl, Guenther, Espay, Alberto J., Tan, Eng‐King, Bhidayasiri, Roongroj, Fung, Victor S.C., Cardoso, Francisco, Trenkwalder, Claudia, Jenner, Peter, Ray Chaudhuri, K., Dafsari, Haidar S.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Hoboken, USA John Wiley & Sons, Inc 01.07.2023 Wiley Subscription Services, Inc
Schlagworte:	Basic Medicine Clinical trials Drug dosages Drug therapy Farmaceutiska vetenskaper LEDD Levodopa levodopa equivalent daily dose levodopa equivalent dose Medical and Health Sciences Medicin och hälsovetenskap Medicinska och farmaceutiska grundvetenskaper Movement disorders Neurodegenerative diseases Non-pharmacological intervention Parkinson's disease Pharmaceutical Sciences Reviews Systematic review levodopa equivalent daily dose LEDD levodopa equivalent dose
ISSN:	0885-3185, 1531-8257, 1531-8257
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!